Items where Division is "Isfahan Neurosciences Research Center" and Year is 2026
![]() | Up a level |
Article
(2026) Micronutrients and tension-type headache: A case-control study on intake and blood levels. Sage Open Chronic Disease. p. 10. ISSN 2755-8428
(2026) Clinical Findings, Antibody Panel and Pathology of Patients with Inflammatory Myopathies in Isfahan Province, Iran. Advanced Biomedical Research. p. 6. ISSN 2277-9175
(2026) Evaluation of respiratory status in patients with myopathy. Journal of Education and Health Promotion. p. 6. ISSN 2277-9531
(2026) Disease Course, Outcomes, and Complications in Pregnant and Breastfeeding Women with Multiple Sclerosis Treated with Rituximab or Ocrelizumab: A Narrative Review. Journal of Research in Pharmacy Practice. p. 7. ISSN 2319-9644
(2026) Bone Mineral Density Loss in Relapsing-remitting Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Matched Case-control Study. International Journal of Preventive Medicine. p. 9. ISSN 2008-7802
(2026) DrugReasoner: Interpretable drug approval prediction with a reasoning-augmented language model. Plos One. p. 12.
(2026) Choroid plexus volume in Alzheimer's disease: A systematic review and meta-analysis. Journal of Alzheimers Disease. pp. 53-64. ISSN 1387-2877
(2026) Claustrum Sign in Hashimoto Encephalopathy Presenting With New Onset Refractory Status Epilepticus (NORSE): First Report of a Rare Phenotype. Clinical Case Reports. p. 5. ISSN 2050-0904
(2026) Prevalence and risk factors of bipolar disorder in central nervous system autoimmune demyelinating diseases. Bmc Psychiatry. p. 10.
(2026) Association between comorbidities and health-related quality of life in patients with multiple sclerosis. Neurologia. p. 8. ISSN 0213-4853
(2026) Theory of Mind and Information Processing Speed in Multiple Sclerosis: Associations With Personality Traits. Brain and Behavior. p. 9. ISSN 2162-3279
(2026) Major depressive disorder in multiple sclerosis and AQP4-antibody positive neuromyelitis optica spectrum disorder: A cross-sectional study on clinical correlates in Iranian patients. Journal of Psychosomatic Research. p. 6. ISSN 0022-3999
(2026) Prevalence and clinical correlates of obsessive-compulsive disorder in central nervous system autoimmune demyelinating diseases: A cross-sectional observational Study. Sage Open Chronic Disease. p. 10. ISSN 2755-8428
(2026) Bipolar disorder in people with multiple sclerosis: an updated systematic review and meta-analysis. Bmc Psychiatry. p. 13.
(2026) Associations between personality traits and cognitive function in multiple sclerosis and neuromyelitis optica spectrum disorder: A cross-sectional study. Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348
(2026) Over reliance on prior expectations in relapsing remitting multiple sclerosis. Iscience. p. 13.
(2026) Recurrent optic neuritis as the first presentation of monoclonal gammopathy of undetermined significance: a case report. Journal of Medical Case Reports. p. 5.
(2026) Cognitive Impairment and Quality of Life in AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study in Iranian Patients. Neurology Research International. p. 8. ISSN 2090-1852
(2026) A Functional Shape Framework for the Detection of Multiple Sclerosis Using Optical Coherence Tomography Images. Sensors. p. 20.
(2026) Effects of binaural beats on acute stress recovery and autonomic regulation in multiple sclerosis: a pilot double-blind randomized controlled trial. Neurological Sciences. p. 13. ISSN 1590-1874
(2026) Slowly Expanding Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Neurosci. p. 14.


